Cytena Solutions: Automate Your Entire Cell Line Development Workflow with BICO Technology

A premier provider of high-precision instruments, Cytena has established itself as a critical partner in the life science sector, delivering innovative solutions that automate complex laboratory processes. Operating as a part of the BICO Group, Cytena leverages the power of bio-convergence to create the future of health by enhancing the efficiency, accuracy, and reproducibility of biological research. Their expertise lies in developing advanced technology that simplifies single-cell isolation, significantly reducing the timelines associated with drug discovery and cell-line development (CLD). By focusing on gentle, verified single cell handling, Cytena empowers researchers to standardize their workflow capabilities, ensuring that every product meets the rigorous demands of modern biotechnology.read more

Why Choose Cytena Products? Advanced Single-Cell Dispensing, Imaging, and Fully Automated CLD

Researchers select Cytena for its unrivaled ability to integrate high-throughput capability with delicate sample handling. For stable cell line development and streamlined single-cell cloning, the brand’s portfolio offers a fully automated solution that minimizes human error and maximizes viability. The core of their offering is the assurance of clonality, a crucial metric in generating regulatory-compliant cell lines for biopharmaceutical applications. Laboratories can visually verify that exactly one cell has been deposited into each well by means of a proprietary single-cell dispenser equipped with automated imaging. This provides documented proof of clonality that is essential for downstream CLD success.

The Cytena ecosystem extends beyond simple isolation; it encompasses a comprehensive workflow designed to automate every stage of the process. For instance, the C.STATION is a versatile workstation that manages the entire cell line development process, including stable cell line development, from cloning to titer assessment. This level of automation allows scientists to focus on data analysis rather than repetitive manual tasks. Furthermore, the technology supports high-throughput screening, enabling the rapid identification of high-producing clones. The system ensures that liquid handling is as precise as the cell isolation itself by integrating a microplate washer and dispenser like the C.WASH, reducing reagent costs and improving assay consistency.​

In the competitive landscape of life science, efficiency is paramount. Cytena addresses this by offering instruments that are not only high-precision but also intuitive to use. The S.NEST microbioreactor, for example, maximizes cell growth by optimizing environmental conditions, thereby accelerating the CLD workflow. This focus on product synergy means that a Cytena workflow is seamless, connecting single-cell dispensing with cultivation and analysis. As a part of BICO, the brand continues to push the boundaries of what is possible in science, providing tools that dispense reagents and isolate cell lines with unmatched accuracy.​

Ultimately, the decision to implement Cytena solutions drives productivity in CLD and stable cell line generation. The ability to dispense single cells gently, coupled with robust automation and high-quality imaging, positions their technology as a cornerstone for any lab focused on cell and gene therapy or antibody production. Facilities can significantly increase their output by adopting these high-throughput systems, maintaining the highest standards of product quality and life sciences excellence simultaneously. The integration of automated cell line development tools ensures that researchers stay at the forefront of innovation, ready to tackle the challenges of tomorrow’s medical breakthroughs.

read less

Fitlers
Category